|
Oncogenes and Tumor Suppressors
Citations 391-400 of 795 total displayed.
|
Past content
(since May 2000):
|
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
- Andrea L. Dewar, Antony C. Cambareri, Andrew C. W. Zannettino, Bernadette L. Miller, Kathleen V. Doherty, Timothy P. Hughes, and A. Bruce Lyons
Blood 2005; 105: 3127-3132.
[Abstract]
[Full text]
[PDF]
Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1–dependent activation of PI-3K/Akt and regulation of Bcl-2 family members
- Vidya Limaye, Xiaochun Li, Chris Hahn, Pu Xia, Michael C. Berndt, Mathew A. Vadas, and Jennifer R. Gamble
Blood 2005; 105: 3169-3177.
[Abstract]
[Full text]
[PDF]
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis
- Alessio Nencioni, Fei Hua, Christopher P. Dillon, Rayka Yokoo, Christoph Scheiermann, Mike H. Cardone, Eleonora Barbieri, Ilaria Rocco, Anna Garuti, Sebastian Wesselborg, Claus Belka, Peter Brossart, Franco Patrone, and Alberto Ballestrero
Blood 2005; 105: 3255-3262.
[Abstract]
[Full text]
[PDF]
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
- Thomas Grimm, Sabine Schneider, Elisabeth Naschberger, Jürgen Huber, Eric Guenzi, Arnd Kieser, Peter Reitmeir, Thomas F. Schulz, Cindy A. Morris, and Michael Stürzl
Blood 2005; 105: 3263-3269.
[Abstract]
[Full text]
[PDF]
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
- Jing Jin Gu, Lalaine Santiago, and Beverly S. Mitchell
Blood 2005; 105: 3270-3277.
[Abstract]
[Full text]
[PDF]
Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish
- David M. Langenau, Cicely Jette, Stephane Berghmans, Teresa Palomero, John P. Kanki, Jeffery L. Kutok, and A. Thomas Look
Blood 2005; 105: 3278-3285.
[Abstract]
[Full text]
[PDF]
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
- Karl J. Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, Hans Skvara, Stefan Florian, Karoline Sonneck, Cahit Akgul, Sophia Derdak, Winfried F. Pickl, Volker Wacheck, Edgar Selzer, Brett P. Monia, Richard Moriggl, Peter Valent, and Christian Sillaber
Blood 2005; 105: 3303-3311.
[Abstract]
[Full text]
[PDF]
KIT exon 8 mutations associated with core-binding factor (CBF)–acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor
- Tobias M. Kohl, Susanne Schnittger, Joachim W. Ellwart, Wolfgang Hiddemann, and Karsten Spiekermann
Blood 2005; 105: 3319-3321.
[Abstract]
[Full text]
[PDF]
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
- Michael Deininger, Elisabeth Buchdunger, and Brian J. Druker
Blood 2005; 105: 2640-2653.
[Abstract]
[Full text]
[PDF]
Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics
- Baijun Fang, Chunmei Zheng, Lianming Liao, Qin Han, Zhao Sun, Xueying Jiang, and Robert C. H. Zhao
Blood 2005; 105: 2733-2740.
[Abstract]
[Full text]
[PDF]
|
|
